Hua L. Yin
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Integrating 3D phenotyping and functional-structural plant models for crop ideotype breeding.
Journal: Nature communications
Published: March 11, 2026
Enhancing Pig Behavior Recognition in Complex Environments: A Transfer Learning-Assisted YOLO11 Network with Wavelet Convolution and Synergistic Attention.
Journal: Animals : an open access journal from MDPI
Published: February 20, 2026
Development and internal validation of a nomogram for predicting 30-day mortality in older patients with hemophagocytic lymphohistiocytosis.
Journal: BMC geriatrics
Published: February 17, 2026
Dual-utility ctDNA in diffuse large B-cell lymphoma: integrated genotyping unveils minimal residual disease dynamics and subtype-specific clonal evolution.
Journal: BMC medicine
Published: October 30, 2025
Penpulimab in combination with lenalidomide and R-GemOx regimen (R2-GemOx-PD1i) in relapsed or refractory diffuse large B-cell lymphoma: a multicenter, single-arm, phase 2 trial.
Journal: BMC medicine
Published: July 08, 2025
Penpulimab combined with rituximab, high-dose methotrexate, and cytarabine (Pen-RMA) in newly diagnosed primary central nervous system lymphoma (PCNSL): a phase 2 trial.
Journal: Blood cancer journal
Published: June 10, 2025
BTG1 Mutation Correlates with Inferior Prognosis in Diffuse Large B-Cell Lymphoma.
Journal: Cancer research and treatment
Published: May 08, 2025
Prognostic Role of SOCS1 Mutations in Diffuse Large B-Cell Lymphoma.
Journal: Cancer research and treatment
Published: April 14, 2025
Clinical implications of ctDNA-based minimal residual disease detection in newly diagnosed peripheral T-cell lymphoma: a single-center cohort study.
Journal: Cell communication and signaling : CCS
Published: March 08, 2025
A Novel CD58 Mutation-Related Signature Predicts Prognosis Risk in Diffuse Large B-Cell Lymphoma Patients.
Journal: Cancer research and treatment
Published: November 27, 2024
SH3GL1-activated FTH1 inhibits ferroptosis and confers doxorubicin resistance in diffuse large B-cell lymphoma.
Journal: Clinical and translational medicine
Published: October 21, 2024
Last Updated: 09/26/2026